https://www.selleckchem.com/products/a-d-glucose-anhydrous.html Aim The CRISPR/Cas9 system is a promising gene-editing tool for various anticancer therapies; however, development of a biocompatible, nonviral and efficient delivery of CRISPR/Cas9 expression systems remains a challenge. Materials & methods Solid lipid nanoparticles (SLNs) were produced based on pseudo and 3D ternary plots. Obtained SLNs and their complexes with PX458 plasmid DNA were characterized and evaluated in terms of cytotoxicity and transfection efficiency. Results SLNs were found to be nanosized, monodispersed, stable and nontoxic. Furthermore, they revealed similar transfection efficiency as the positive control. Conclusion Overall, we have achieved a good SLN basis for CRISPR/Cas9 delivery and have the potential to produce SLNs with targeted anticancer properties by modifying production parameters and components to facilitate translating CRISPR/Cas9 into preclinical studies.Reports an error in "Is bimanual interference affected in the case of a central proprioceptive loss? New insight from a left-brain-damaged single-case study" by Federica Scarpina, Sofia Tagini, Marco Rabuffetti, Giovanni Albani, Francesca Garbarini and Alessandro Mauro (Neuropsychology, 2020[May], Vol 34[4], 479-492). In the article "Is Bimanual Interference Affected in the Case of a Central Proprioceptive Loss? New Insight From a Left-Brain-Damaged Single-Case Study," by Federica Scarpina, Sofia Tagini, Marco Rabuffetti, Giovanni Albani, Francesca Garbarini, and Alessandro Mauro (Neuropsychology, 2020, Vol. 34, No. 4, pp. 479-492, https//doi.org/10.1037/neu0000624), in the author note, the Scientific Institute for Research, Hospitalization and Healthcare was incorrectly listed as the Scientific Hospitalization and Treatment Institute in the affiliations for Federica Scarpina, Giovanni Albani, and Alessandro Mauro, and was missing from the affiliation for Marco Rabuffetti. The online version of the article haence of a vis